Cargando…
Dual checkpoint inhibitor-associated eosinophilic enteritis
BACKGROUND: Eosinophilia has been reported as a rare, new biological effect of immune checkpoint inhibition that may be associated with improved treatment response and the development of immune-related adverse events. CASE PRESENTATION: We report a case of dual checkpoint inhibitor-associated hypere...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858706/ https://www.ncbi.nlm.nih.gov/pubmed/31730503 http://dx.doi.org/10.1186/s40425-019-0743-5 |
_version_ | 1783471009167310848 |
---|---|
author | Yang, J. Lagana, S. M. Saenger, Y. M. Carvajal, R. D. |
author_facet | Yang, J. Lagana, S. M. Saenger, Y. M. Carvajal, R. D. |
author_sort | Yang, J. |
collection | PubMed |
description | BACKGROUND: Eosinophilia has been reported as a rare, new biological effect of immune checkpoint inhibition that may be associated with improved treatment response and the development of immune-related adverse events. CASE PRESENTATION: We report a case of dual checkpoint inhibitor-associated hypereosinophilia and eosinophilic enteritis in a patient with advanced cutaneous melanoma. Rapid resolution of peripheral eosinophilia and associated symptoms was achieved with steroids alone. CONCLUSIONS: Immune checkpoint inhibition can trigger inflammation in virtually any organ in the body, leading to diverse clinical manifestations. To our knowledge, this is the first case report of eosinophilic enteritis due to ipilimumab plus nivolumab. |
format | Online Article Text |
id | pubmed-6858706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68587062019-11-29 Dual checkpoint inhibitor-associated eosinophilic enteritis Yang, J. Lagana, S. M. Saenger, Y. M. Carvajal, R. D. J Immunother Cancer Case Report BACKGROUND: Eosinophilia has been reported as a rare, new biological effect of immune checkpoint inhibition that may be associated with improved treatment response and the development of immune-related adverse events. CASE PRESENTATION: We report a case of dual checkpoint inhibitor-associated hypereosinophilia and eosinophilic enteritis in a patient with advanced cutaneous melanoma. Rapid resolution of peripheral eosinophilia and associated symptoms was achieved with steroids alone. CONCLUSIONS: Immune checkpoint inhibition can trigger inflammation in virtually any organ in the body, leading to diverse clinical manifestations. To our knowledge, this is the first case report of eosinophilic enteritis due to ipilimumab plus nivolumab. BioMed Central 2019-11-15 /pmc/articles/PMC6858706/ /pubmed/31730503 http://dx.doi.org/10.1186/s40425-019-0743-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Yang, J. Lagana, S. M. Saenger, Y. M. Carvajal, R. D. Dual checkpoint inhibitor-associated eosinophilic enteritis |
title | Dual checkpoint inhibitor-associated eosinophilic enteritis |
title_full | Dual checkpoint inhibitor-associated eosinophilic enteritis |
title_fullStr | Dual checkpoint inhibitor-associated eosinophilic enteritis |
title_full_unstemmed | Dual checkpoint inhibitor-associated eosinophilic enteritis |
title_short | Dual checkpoint inhibitor-associated eosinophilic enteritis |
title_sort | dual checkpoint inhibitor-associated eosinophilic enteritis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858706/ https://www.ncbi.nlm.nih.gov/pubmed/31730503 http://dx.doi.org/10.1186/s40425-019-0743-5 |
work_keys_str_mv | AT yangj dualcheckpointinhibitorassociatedeosinophilicenteritis AT laganasm dualcheckpointinhibitorassociatedeosinophilicenteritis AT saengerym dualcheckpointinhibitorassociatedeosinophilicenteritis AT carvajalrd dualcheckpointinhibitorassociatedeosinophilicenteritis |